The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer

Balakan, Ozan; KALENDER, MEHMET; Suner, Ali; Cengiz, Beyhan; ÖZTUZCU, SERDAR; Bayraktar, Recep; Borazan, Ersin; BABACAN, TANER; CAMCI, CELALETDİN

doi:10.12659/msm.890459

The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer

Balakan O., KALENDER M. E., Suner A., Cengiz B., ÖZTUZCU S., Bayraktar R., ...Daha Fazla

MEDICAL SCIENCE MONITOR, cilt.20, ss.1419-1425, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20
Basım Tarihi: 2014
Doi Numarası: 10.12659/msm.890459
Dergi Adı: MEDICAL SCIENCE MONITOR
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1419-1425
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Urotensin II is a vasoactive polypeptide. It is known that some vasoactive polypeptides are produced and secreted by tumor cells, and act as a paracrine growth stimulant. The aim of this study was to examine the relationship between urotensin II and its receptor's messenger RNA expression in breast cancer.